Nexus Medical LLC

Thank you for visiting the Nexus Medical Linked In Website.

Nexus Medical has developed a next generation infusion therapy technology which is called Nexus TKO® (TKO – abbreviation for To Keep Open).

Our new Nexus TKO technology is designed to simplify the complexity and variability of I.V. Therapy by Reducing Blood Reflux in peripheral, PICC and CVC catheters

The Nexus TKO Anti-Reflux technology insures Blood Reflux Protections 24/7™ for your peripheral, PICC and CVC catheters.

Recent clinical studies and white paper confirm documented advantages of the Nexus TKO Anti-Reflux technology by preventing blood reflux.

51% of peripheral catheters lasted 72 hours1.
61% of peripheral catheters lasted 96 hours1.
89% decrease in tPA usage while eliminating heparin flushes in PICC and CVC catheters2.
41% improvement in PICC & Central Line Occlusions1.

Preventing Blood Reflux reduces I.V. catheter complications such as occlusions, infiltrations, phlebitis which can lead to unscheduled catheters restarts and blood stream infections.

Please find additional information for your further review and feel free to use the above contact information to receive immediate follow up.

Again thanks for your interest in Nexus Medical and our Nexus TKO Anti-Reflux technology.

Company’s Keywords:

nexus tko antireflux needle free device, neonatal intensive care infusion therapy systems, anesthesia infusion therapy systems, infusion therapy administration systems, pharmacy admixtures compounding systems